---
title: NIR-II Probes for Deep-Tissue Imaging
url: https://www.emergentmind.com/topics/nir-ii-probes
type: topic
---

# NIR-II Probes for Deep-Tissue Imaging

Near-infrared-II (NIR-II) probes are optical emitters that operate within the spectral range of approximately 1000–1400 nm (commonly designated as the second biological window or NIR-II window). These fluorophores are engineered to leverage reduced tissue scattering and minimized endogenous autofluorescence in biological specimens, facilitating deep-tissue, high-resolution imaging. Representative NIR-II probes include single-walled carbon nanotubes (SWNTs), ultrashort carbon nanotubes with luminescent color centers, and quantum-emitting color centers in diamond. Their distinct photophysical properties, surface chemistry, and imaging performance are actively being developed and benchmarked for biomedical research, photonics, and quantum applications [1105.3536][1211.4269][2501.08254][2412.11054].

## 1. Physical Basis and Spectral Properties

NIR-II probes are defined by their emission in the range 1000–1400 nm, which yields optimal optical penetration because the reduced scattering coefficient in tissue, $\mu_s'(\lambda) \propto \lambda^{-w}$, decreases with increasing wavelength ($w \approx 0.22$–$2.4$ depending on tissue composition) [1105.3536][1211.4269]. Water absorption increases slightly in NIR-II (e.g., $\mu_a,\mathrm{water} \approx 0.098$ mm$^{-1}$ at 800 nm and $\approx 0.14$ mm$^{-1}$ at 1300 nm), but the overall effect is maximization of the effective penetration depth $\delta$, as given by the diffusion model:
$$
\delta = \left[3 \mu_a (\mu_a + \mu_s') \right]^{-1/2}
$$
Excitation is typically performed between 785–808 nm using diode lasers or filtered lamps, while emission is collected with long-pass filters (e.g., 900 nm, 1100 nm) and detected by InGaAs cameras sensitive to 1.1–1.7 μm [1105.3536][1211.4269]. SWNTs and related probes exhibit multiple emission peaks spanning 1000–1400 nm, with intensity maxima set by their microstructure or (n,m) chirality (SWNTs: $\sim1130$–$1320$ nm; ultrashort CNT color centers, E$_{11}^*$: $1108$–$1140$ nm; diamond $N_2V^-$ ZPL: $986$ nm, vibronic sideband: $1120$ nm) [2501.08254][2412.11054].

## 2. Probe Formulation, Functionalization, and Biocompatibility

The colloidal and biological properties of NIR-II probes are highly dependent on their functionalization strategies:

- **SWNT-based probes**: Preparation from HiPCO or CoMoCAT SWNTs involves surfactant-assisted dispersion (e.g., sodium cholate, sodium deoxycholate), ultracentrifugation to remove bundles, and exchange into DSPE-mPEG (methoxy-polyethylene glycol-phospholipid, MW ~5,000), which imparts colloidal stability, resistance to protein adsorption, prolonged circulation ($t_{1/2} \approx 5$ h), and minimal cytotoxicity [1105.3536][1211.4269].
- **IRDye-800–conjugated SWNTs**: Covalent coupling of IRDye-800 NHS ester to PEG–NH$_2$-coated SWNTs yields hybrid probes with emission in both NIR-I (ICG, $800$ nm) and NIR-II (SWNT backbone $1.1$–$1.4$ μm); the conjugation reduces dye quantum yield by up to 60% due to quenching but ensures water solubility and biocompatibility [1211.4269].
- **Ultrashort carbon nanotubes with luminescent color centers (uCCNTs)**: Synthesis routes include (A) sidewall aryl functionalization followed by oxidative cutting, and (B) tip-sonication of monodisperse SWNTs followed by oxygen-defect implantation. Surface passivation is achieved via surfactant-exchange into phospholipid–PEG (PLPEG5000), essential for imaging in physiological media [2501.08254].
- **Detonation nanodiamond (DND) color centers ($N_2V^-$)**: Formation relies on nitrogen doping and vacancy generation (HPHT or CVD diamond), with air oxidation facilitating stable NIR-II PL on nanoparticle surfaces. PLPEG-type coatings are similarly employed for biocompatibility and cellular uptake [2412.11054].

## 3. Photophysical Mechanisms and Quantum Yield

Photon absorption and emission in NIR-II agents are dictated by their characteristic electronic structure and defect-induced trap states:

- **SWNTs**: Quantum yield (Φ) in biocompatible DSPE-mPEG suspension is low, typically $Φ \approx 10^{-3}$–$10^{-2}$, but surfactant-exchange and defect engineering can raise single-particle Φ to $2.5\%$–$12\%$ (oxygen-defect ultrashorts) [2501.08254][1211.4269]. Emission arises from exciton recombination at localized trap states (color centers), shifting the PL maximum into deep NIR-II.
- **DND $N_2V^-$ centers**: N₂V⁻ exhibits a broad NIR-II emission band (950–1400 nm), with a zero-phonon line at $986.5 \pm 0.5$ nm (room temperature linewidth $10$–$11$ nm in nanoparticles), and vibronic sideband peaking near $1120$ nm [2412.11054]. PL lifetime is $\tau = 0.323 \pm 0.002$ ns, corresponding to a spontaneous emission rate $\gamma = 1/\tau \approx 3.1 \times 10^9$ s$^{-1}$.
- **Brightness metric**: Photon count rates for NIR-II probes span a wide range depending on formulation and imaging conditions. DNDs with N₂V⁻ can yield $\sim 30$ kcps per aggregate in cells, with SWNTs emitting $\sim 10$–$100$ kcps and quantum dots (PbS/CdHgTe) up to $10^6$ cps [2412.11054]. Single ultrashort CNTs achieve $\sim 12\%$ quantum yield and brightness of $3.8 \times 10^6$ M$^{-1} \cdot$cm$^{-1}$ [2501.08254].

## 4. Imaging System Performance and Dynamic Contrast

NIR-II imaging exploits reduced tissue scattering and enhanced contrast, implemented via advanced camera systems and dynamic analysis:

| Imaging Modality            | Spatial Resolution | Temporal Resolution         | Penetration Depth       |
|-----------------------------|--------------------|----------------------------|-------------------------|
| NIR-II probe (SWNT/uCNT)    | Down to $30~\mu$m  | $<200$ ms/frame            | $1$–$3$ mm (up to $5$ mm)|  
| NIR-I dye (ICG, QDs)        | $>$100~$\mu$m      | (comparable)               | $<$1 mm                 |
| micro-CT/MRI                | $\gtrsim 40~\mu$m$^\ast$ | $2$ h scan / seconds per slice | Whole body, low contrast|
| Ultrasound (Doppler)        | Limited at depth   | up to $1$ kHz              | Several cm, lower SBR   |

$^\ast$Micro-CT's effective resolvable vessel diameters are $\geq 100~\mu$m [1211.4269].

- Real-time anatomical imaging (e.g., mouse organs during SWNT injection) is accomplished with video rates $>14$ fps (SWNTs: $50$ ms exposure, $19$ ms readout) [1105.3536].
- Principal Component Analysis (PCA) is used to enhance dynamic contrast; PCA decomposition of the pixel-time intensity matrix $X$ allows separation of organs and vessel phases based on blood-flow kinetics [1105.3536][1211.4269]. Individual organs are mapped to distinct principal components and color-coded for visualization.
- Quantitative blood-flow velocity extraction employs both flow-front tracking ($v = \Delta x / \Delta t$) and intensity-rise analysis ($v = k \cdot dI/dt$, calibrated coefficient $k$) for absolute measurement of vascular hemodynamics, spanning velocities from $0.16$ cm/s (ischemic) to $5$ cm/s (healthy) [1211.4269].

## 5. Comparative Evaluation and Emerging Probes

NIR-II imaging demonstrates several advantages over established modalities and is expanding beyond SWNTs to new materials:

- **Feature Fidelity and Depth**: SWNT-based probes exhibit reduced feature broadening at increased depth compared to NIR-I dyes, yielding higher anatomical resolution through several millimeters of tissue [1105.3536][1211.4269].
- **Photostability**: DND color centers ($N_2V^-$) and ultrashort color-center CNTs show minimal blinking and photobleaching, supporting long-duration single-particle and aggregate imaging [2412.11054][2501.08254].
- **Biological Compatibility**: PEGylation and related stealth surface coatings (DSPE-mPEG, PLPEG5000) are essential for stability and reduced toxicity, preserving quantum yield and circulation time [1105.3536][1211.4269][2501.08254].
- **Practical Applications**: NIR-II imaging is deployed for non-invasive vascular mapping, dynamic contrast angiogenesis studies, deep organ functional imaging, pre-clinical diagnostics, image-guided surgery, and high-speed single-particle tracking in thick tissue [1105.3536][1211.4269][2501.08254][2412.11054].
- **Telecom and Quantum Integration**: N₂V⁻ emission overlaps the fiber-optic O-band (1260–1360 nm), suggesting direct compatibility for on-chip photonic platforms and quantum sensing [2412.11054].

## 6. Practical Design Guidelines and Future Directions

Development of NIR-II probes is guided by optimization strategies tailored to application and imaging demands:

- **Defect Chemistry**: Oxygen defects via Fenton-like reaction yield the highest single-tube quantum yields (up to $12\%$, [2501.08254]).
- **Defect Density**: Control of trap density ($\sim4$–$8$ defects/$\mu$m) maximizes brightness by balancing radiative recombination against non-radiative quenching [2501.08254].
- **Quenching Minimization**: Over-sonication, aggressive oxidation, and uncontrolled functionalization increase quenchers and diminish brightness—protocol selection is essential [2501.08254].
- **Surface Coating**: Exchange into PLPEG (or DSPE-mPEG for SWNTs) is mandatory for bioimaging; stability is confirmed by PL peak shifts and colloidal behavior [1105.3536][1211.4269][2501.08254].
- **Instrumentation**: Optimal excitation is achieved at the E$_{11}$ absorption ($985$ nm for CNTs), with emission collection via $>1064$ nm long-pass filters and noise-mitigated InGaAs detection [2501.08254]. For nanoscale 3D tracking, engineered point-spread functions (Double-Helix phase masks) yield sub-10 nm localization precision in thick brain tissue [2501.08254].

*This suggests that ultrabright, ultra-short, photostable NIR-II nano-emitters are positioned to advance deep-tissue bioimaging, fiber communications, and quantum photonic technologies. Key open questions remain regarding quantum yield quantification, site-controlled defect fabrication, charge-state management, and spectrally selective imaging in sub-100 nm particles [2412.11054].*

Source: https://www.emergentmind.com/topics/nir-ii-probes